Thursday, November 19, 2026

Fw: Ref.: (LML) New Publications On Cross-Cutting Issues In NTDs. October, 2026


 


Leprosy Mailing List –  November 19,  2026 


Ref.:  (LML) New Publications On Cross-Cutting Issues In NTDs. October, 2026

From: Elizabeth Talatu Williams, Amsterdam, the Netherlands

____________________________________________________________________________



Dear Colleagues,

We are pleased to share the October 2026 edition of the InfoNTD newsletter, featuring the latest research, practical resources, and updates from across the NTD community.

This edition highlights the WHO Global Report on Neglected Tropical Diseases 2026, which presents the mid-term evaluation of progress towards the 2030 NTD Road Map targets. We also share resources from the UPLIFT project on strengthening community-based groups for people affected by skin NTDs.

The latest publications explore a range of cross-cutting NTD issues, including new diagnostic approaches, mass drug administration, WASH, cost-effectiveness of interventions, maternal and child health, and the integration of NTD services into primary healthcare.

We hope this edition provides valuable insights and resources to support your work and strengthen collaboration across the NTD community.

Feel free to contact us if you would like access to full-text articles not directly available through InfoNTD, or if you would like support with literature searches.


Warm regards,


Elizabeth Talatu Williams

www.InfoNTD.org
info@InfoNTD.org

 



 



 



Literature Reviews

 



Water, sanitation, and hygiene in soil-transmitted helminth control: A scoping review of evidence gaps across transmission pathways
Velleman Y, Straily A, Secor EW., et al. PLOS Global Public Health. Public Library of Science (PLoS). 2026; 6 (10): 1 - 20. 


Soil-transmitted helminths and childhood development: Nutrition, anemia, cognitive outcomes, and school-based deworming
Ahmed B, Ahmed A, Tanveer R. Asian Pacific Journal of Tropical Medicine. Ovid Technologies (Wolters Kluwer Health). 2026; 19 (11): 473 - 485.


Automation and machine learning in schistosomiasis drug discovery
Irshaid S, Hamway Y, Geoui T, et al. Frontiers in Drug Discovery. Frontiers Media SA. 2026; 6 (1906539): 1 - 18. 


Leishmaniasis in the Middle East: A Narrative Review of Epidemiological Characteristics and Transmission Determinants
Alharbi B, Ahmed M. Pathogens. MDPI AG. 2026; 15 (10): 1 - 17. 

 



 



Practical materials

 



Global report on neglected tropical diseases 2026: mid-term evaluation of the road map implementation [WHO]


Strengthening Community-Based Groups for People Affected by Skin-NTDs: Lessons of the UPLIFT Project Webinar
[Effect Hope]


UPLIFT Implementation Manual for Community-Based Groups [Effect Hope]


UPLIFT Facilitation Guide for Community-Based Groups [Effect Hope]

 



 



New publications

 



Strengthening access to people-centred mental healthcare for people affected by skin neglected tropical diseases in Nigeria: a pilot study
Afolaranmi T, Dogo J, Akinnusi P, et al. International health. 2026.


Evaluating the cost of self-care: Impact of enhanced morbidity management protocol on people living with lymphatic filariasis in Bangladesh
Williams T, Karim M, Siddiqui S, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 - 21


Integrating neglected tropical diseases into primary healthcare services in Ghana: Results from an initial pilot
Dadzie A, Ananya S, Tougoue J, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 - 15. 


Microscopically detectable maternal schistosomiasis at delivery in Eastern Uganda: Prevalence, microscopy-based species distribution and associated household WASH characteristics in a hospital-based cross-sectional study
Sande G, Kasujja M, Okurut E, et al. PLOS Global Public Health. Public Library of Science (PLoS). 2026; 6 (10): 1 - 17. 


Evaluation of primary intervention on knowledge, attitude and preventive practices on onchocerciasis among adults in south west Nigeria
Adejumo O, Adebimpe W, Adeleke M, et al. Research Journal of Health Sciences. African Journals Online (AJOL). 2026; 14 (3): 260 - 269


“My feet are no longer swollen”: Testing a co-designed podoconiosis protective footwear among rural female farmers in Rwanda
Igihozo G, Dusabe L, Uwizeyimana J, et al. PLOS Global Public Health. Public Library of Science (PLoS). 2026; 6 (10): 1 - 19. 


Feasibility of integrating thermotherapy (TT) for the treatment of Cutaneous Leishmaniasis into the primary healthcare facilities in east gurage zone, ethiopia: a protocol for an implementation research study
Ejigu D, Fekadu A, Kinfe M, et al. BMC Primary Care. Springer Science and Business Media LLC. 2026; 27 (1): 1 - 8. 


Pragmatic weight estimation for dosing of a new paediatric treatment for schistosomiasis prevention and control in preschool-aged children: a feasibility study in Uganda and Côte d’Ivoire
Monnier N, Beinamaryo P, Wells M, et al. Infectious Diseases of Poverty. Springer Science and Business Media LLC. 2026; 15 (1): 1 - 13. 


Developing a scoring tool for assessing adherence to morbidity management and disability prevention (MMDP) practices in patients with filarial lymphedema: A pilot study
Ramar G, Sadhasivam A, Gnanasekaran V, et al. PloS one. 2026; 21 (9): 1 - 8. 


Hospital-Based Seroprevalence and Socio-Environmental Predictors of Human Leishmaniasis in Baringo County, Kenya: Implications for One Health Surveillance and Control
Maingi H, Chege J, Yapi R, et al. Pathogens. MDPI AG. 2026; 15 (10): 1 - 19. 


Evaluation of the clinical performance of two new onchocerciasis rapid diagnostic tests in districts targeted for elimination in Ghana
de Souza D, Ashong Y, Afatodzie S, et al. Scientific Reports. Springer Science and Business Media LLC. 2026.


Preventive Chemotherapy at Crossroads: Progress, the Funding Crisis, and Strategic Priorities for Achieving the 2030 WHO Neglected Tropical Diseases Road Map
Mogaji H. Tropical Medicine and Infectious Disease. MDPI AG. 2026; 11 (11): 1 - 15. 


Evaluating the impact of triple-drug mass drug administration using human and mosquito-based indicators of lymphatic filariasis in Samoa, 2019 – 2024
Mayfield H, McLure A, Rigby L, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 - 16. 

 


Burden and Risk Factors of Urinary Schistosomiasis and Bacteriuria Coinfections Among Schoolchildren in an Endemic District in the Ashanti Region, Ghana
Frimpong P, Yar D, Awua-Boateng N, et al. Journal of parasitology research. 2026.


Epidemiology of helminth infections in adults in rural rainforest communities of the Nkam-Wouri River Basin, Littoral Region of Cameroon: Implications for NTDs elimination using preventive chemotherapies
Ebob A, Gandjui N, Lenz B, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 - 20. 


Assessing diagnostic accuracy of onchocerciasis rapid diagnostic tests using Bayesian latent class models
Norman J, Bassabi-Alladjie N, Boko-Collins P, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 – 13.


Spatiotemporal evaluation of the Schistosomiasis control program indicators in an endemic area in Northeastern of Brazil: an historical overview of 46 years (1977 to 2023)
Barbosa V, Damasceno F, Andrade L, et al. Parasitology Research. Springer Science and Business Media LLC. 2026.


Cost-benefit analysis of arpraziquantel compared to standard of care for schistosomiasis among pre-school age children in Tanzania: an early health economic evaluation
Chua B, Chaowanasawat P, Tsui T, et al. The Lancet Regional Health - Africa. Elsevier BV. 2026.


Assessment of the programmatic effectiveness of single-dose albendazole against soil-transmitted helminthiasis in school-age children following seven rounds of annual mass drug administration in selected counties of Kenya
Okoyo C, Chepchieng G, Kemunto E, et al. Frontiers in Tropical Diseases. Frontiers Media SA. 2026.


Strengthening health research capacity: The role of research platforms in Chagas disease and leishmaniasis
da Silva R, de Vasconcelos D, Antunes M, et al. Physis: Revista de Saúde Coletiva. FapUNIFESP (SciELO). 2026; 36 (1): 1 - 21. 


Geostatistical analysis of baseline prevalence and treatment history drastically reduces the cost of soil-transmitted helminth impact assessment surveys
Fronterrè C, Johnson O, Giorgi E, et al. BMC Global and Public Health. Springer Science and Business Media LLC. 2026; 4 (1): 1 - 9.


“We don’t know schistosomiasis can affect the female reproductive system and increase the risk of HIV”: A mixed-methods analysis reveals gaps in risk factor determinants and health consequences of female genital schistosomiasis in Southern Chad
Asongha M, Ngakia T, Akawung P, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 - 20. 


A community-based participatory research and community health workers-led health education strategy for schistosomiasis control among schoolchildren in Pemba Island, Zanzibar: a cluster-randomized trial
Li X, Wang Y, He M, et al. Infectious diseases of poverty. 2026; 15 (1): 1 - 14. 


Knowledge, attitudes and educational exposure regarding neglected tropical diseases among medical students and residents in Italy: a nationwide multicenter survey from the Italian Society for Tropical Medicine and Global Health (SIMET ETS)
Guido G, Buonamassa R, Rossi B, et al. Infection. Springer Science and Business Media LLC. 2026.


Schistosoma haematobium infection among school age children in two peri-urban areas of Lusaka, Zambia: A cross-sectional study
Mutengo M, Mwansa J, Chisanga K, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 - 14. 

 



 



Upcoming Events

 



International Symposium on Infectious Diseases and Global Health 2027
Date and Location: May 3 – 4, 2027, Kuala Lumpur, Malaysia
 
The International Symposium on Infectious Diseases and Global Health (ISIDGH 2027) is a premier international forum dedicated to addressing the evolving challenges of infectious diseases and promoting innovative strategies to improve global health outcomes. The theme is strengthening global health systems and advancing innovations to combat infectious diseases.
 
Abstract submissions are currently open!
Earlybird registration deadline: November 19, 2026
Final call registration deadline: April 27, 2027
 

 


European Congress on Tropical Medicine and International Health (ECTMIH) 2027
Date and Location: October 25 – 28, 2027, Barcelona, Spain
 
The European Congress on Tropical Medicine and International Health (ECTMIH) is a biennial event that convenes the global health community to exchange knowledge, foster collaboration, and shape the future of global health. Initiated by FESTMIH in 1995, ECTMIH is the premier forum for driving debate on global health equity and scientific innovation. Since its first edition, ECTMIH has grown into a key platform connecting stakeholders from Europe and low- and middle-income countries.

Call for organised sessions and symposia is currently open!
Application Link:
Call for Organised Sessions and Symposia – ECTMIH 2027
Deadline: December 15, 2026

 




GDPR & the InfoNTD newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our
privacy statement and mailing list.

InfoNTD sends out monthly e-mails with an overview of recent publications on NTDs and cross-cutting issues. The purpose of this activity is to keep subscribers up to date.

InfoNTD will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can
update your preferences or unsubscribe from this list at any time.

 


 





 

____________________________________________________________________________

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << edit...@gmail.com


--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/leprosymailinglist/5363d844-482b-4979-878d-3391c2204860n%40googlegroups.com.

Sunday, November 8, 2026

Hi, Please do accept my apologies


Hi,

I will appreciate your response. Please do accept my apologies.I do not wish to invade your privacy, I had written an earlier email to you but without response. Please, I want to know if you received it or should I resend it to you?

Kind regards,
SK Williams

Thursday, November 5, 2026

Fw: Ref.: (LML) Introducing LRI's Multi-Annual Strategic Plan 2026–2029 and Workshop on Research Dissemination and Policy Translation


 

 

Leprosy Mailing List –  November 5,  2026

 

Ref.:  (LML) Introducing LRI's Multi-Annual Strategic Plan 2026–2029 and Workshop on Research Dissemination and Policy Translation

From: Leprosy Research Initiative, Amsterdam, the Netherlands

____________________________________________________________________________

 

 





Introducing LRI’s Multi-Annual Strategic Plan 2026-2029
 

The Leprosy Research Initiative has launched its new Multi-Annual Strategic Plan (2026-2029), setting out an ambitious roadmap to strengthen research, build capacity, and accelerate the translation of evidence into action.


What's new?

The new strategy strengthens four important priorities that will cut across all funded research:

  • Leprosy Plus
    Encouraging research that recognises the interconnected realities of leprosy, other NTDs, disabilities, and broader public health challenges.
  • Integration
    Supporting evidence on how leprosy services can be effectively delivered through wider health systems while maintaining quality and accessibility.
  • Translation
    Promoting stronger pathways from research findings to implementation, policy development, and real-world impact.
  • Cost-Effectiveness
    Addressing an important evidence gap by encouraging studies that assess value for money and inform resource allocation decisions.

Research priority themes
Over the coming years, LRI will invest in research focused on:

  1. Diagnostics, transmission, and prophylaxis
  2. Leprosy complications 
  3. Stigma, discrimination, and mental well-being
  4. Health systems 

Why this matters

Despite significant progress, important challenges remain for a world free from leprosy and neglected tropical diseases (NTDs).

By supporting high-quality, operationally relevant research and strengthening local research leadership, LRI aims to ensure that evidence directly contributes to better policies, stronger programmes, and improved outcomes for those most affected.

We look forward to working with researchers, policymakers, people affected by leprosy, and partners across the global health community to bring this strategy to life.

Read more about the LRI Multi-Annual Strategic Plan (2026-2029)
on our website and explore the updated research priorities.

 




From research findings to real-world impact
 

Research can only achieve its full potential when findings are used to inform decisions, improve programmes, and influence policy. With this in mind, LRI recently organised a Research Dissemination and Policy Translation Workshop in New Delhi, India, for LRI researchers working in leprosy and related neglected tropical diseases.

 

The workshop was designed to help participants strengthen their skills in identifying target audiences, tailoring research messages, engaging policymakers, and communicating evidence through compelling storytelling.

One of the key lessons that emerged was that effective communication requires more than sharing data. Researchers must understand who they are trying to reach, what information those audiences need, and how evidence can be presented in a way that encourages action.

Throughout the workshop, participants developed practical dissemination products, including policy briefs, advocacy materials, and success stories. They also created dissemination action plans and identified concrete next steps for increasing the uptake of their research.

Beyond the technical skills acquired, participants highlighted the value of peer learning and the opportunity to exchange experiences with colleagues working in different countries and contexts.

The workshop aligns closely with LRI's strategic commitment to strengthening research capacity and supporting the translation of knowledge into policy and practice.

As participants returned to their institutions and projects, the focus now shifts from planning to implementation. LRI looks forward to seeing how the skills, tools, and commitments developed during the workshop help ensure that research findings contribute to tangible improvements for people affected by leprosy and related neglected tropical diseases.


Research generates evidence. Effective communication turns evidence into impact.

 

____________________________________________________________________________

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << edit...@gmail.com


--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/leprosymailinglist/864f8c66-f763-4393-a724-3bfb7a743756n%40googlegroups.com.

Monday, November 2, 2026

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy. October, 2026


 

Leprosy Mailing List –  October 2,  2026

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy. October, 2026

From: Elizabeth Talatu Williams, Amsterdam,. The Netherlands

____________________________________________________________________________

 Dear colleagues,

We are pleased to share the October 2026 edition of the Infolep newsletter, featuring new research, case reports, publications, global updates and upcoming events from across the leprosy field.

This month's featured research explores health-seeking behaviours among persons cured of leprosy in Ghana, factors affecting disability among people affected by leprosy in Indonesia, and the potential of artificial intelligence and digital health in leprosy diagnosis.

Our latest publications section covers a wide range of topics, including leprosy epidemiology in Mexico and Tanzania, barriers to accessing biomedical care, advances in diagnostic techniques, and historical evidence of leprosy revealed through paleogenomics. 

The case reports section features challenging clinical presentations, including leprosy mimicking other neurological conditions, delayed diagnosis, and a rare case of leprosy-associated kidney disease in an adolescent.

In our news and events section, we share global developments in leprosy elimination, updates on national initiatives, stories of people affected by leprosy, and the discovery of a medieval leprosy hospital in the UK. We also highlight the upcoming 13th Edition of the EDCTP Forum, taking place in Madrid, Spain, from 5–9 April 2027.

Stay connected with Infolep for the latest research, resources, news and opportunities supporting the global leprosy community.


Warm regards,
Elizabeth Talatu Williams

www.leprosy-information.org
info@infolep.org
 




 



Featured Research Spotlight

Understanding influences on health-seeking behaviours among persons cured of leprosy in the Godokpe community, Volta Region of Ghana: A qualitative descriptive study
Duboh RJ, Delali DK, Manu E, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (9): 1 - 19.


Comparative Analysis of Factors Affecting Disability Among Leprosy Patients Across Five Endemic Regions in Indonesia
Wahyuni LK, Nelfidayani, Irawati Y, et al. International Journal of Environmental Research and Public Health. MDPI AG. 2026; 23 (10): 1 - 20.


Artificial Intelligence and Digital Health in the Diagnosis of Leprosy: Current Advances and Future Perspectives
Rivera G, Rubio R, Rodríguez L, et al. Acta Microbiologica Hellenica. MDPI AG. 2026; 71 (4): 1 - 9.

 



 



Other New Publications

Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.

 



Leprosy in Sonora, Mexico: A 14-Year Retrospective Study of Clinical, Epidemiological, and Sociodemographic Characteristics
Preciado Gocobachi EE, Salgado Salomón MA, Navarro Armendariz GA, et al. Tropical Medicine and Infectious Disease. MDPI AG. 2026; 11 (10): 1 - 11.


Geospatial inequalities in severe leprosy disability in Pernambuco before and during COVID-19
Melo ATL, Galvão PVM, Correia CDC. The Brazilian Journal of Infectious Diseases. Elsevier BV. 2026; 30 (5): 1 - 5. 


Epidemiological profile of leprosy cases at Nazareti Leprosy Center, Tanzania: A retrospective analysis (2000–2024)
Machang’u R, Kagesyeko JN, Edward M, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (9): 1 - 12.


Dermoscopic Spectrum of Nail Alterations in Pediatric Leprosy: A Cross-Sectional Study from an Endemic Settings
Gunawan H, Menaldi SL, Resna EN, et al. Clinical, Cosmetic and Investigational Dermatology. Informa UK Limited. 2026.


Differential Expression and Correlation of High-mobility Group Box 1 and Vascular Endothelial Growth Factor Messenger Ribonucleic Acid across Leprosy Clinical Groups and Healthy Controls: A Cross-sectional Study
Noviyanthi RA, Natzir R, Djawad K, et al. The International Journal of Mycobacteriology. Ovid Technologies (Wolters Kluwer Health). 2026; 15 (3): 272 - 281. 


Clinical and Bacteriological Profile of Leprosy: A Case Series of 18 Patients From A Tertiary Care Hospital
Dr. Sneh Lata, Dr. Shivani, Dr. Rupali, et al. International Journal of Life Sciences, Biotechnology and Pharma Research. 2026; 15 (9): 1 - 7. 

 


Barriers to biomedical care: Qualitative insights into health-seeking behaviors and systemic challenges among people affected by leprosy in Tanzanian communities
Muhigi SA, Mashoto K, Chiduo M, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2026; 20 (10): 1 - 13. 


Declining Leprosy-Related Hospitalization Rates and Increasing In-Hospital Case Fatality in Brazil: A Nationwide Ecological Time-Series Study, 2008-2023
de Souza BC, Dos Santos JBM, Dantas GG, et al. Cureus. Springer Science and Business Media LLC. 2026; 18 (10): 1 - 22. 


Histopathology of Erythema Nodosum Leprosum With Emphasis on Post-multidrug Therapy Considerations: A Narrative Review
Shukla DT, Bhensadadiya M. Cureus. Springer Science and Business Media LLC. 2026; 18 (10): 1 - 9. 


Immunohistochemical Evaluation of S100 and CD163 in Leprosy with Emphasis on Polar Leprosy
Joshi AL, Somalwar SB, Prabhala S, et al. Annals of African Medicine. Ovid Technologies (Wolters Kluwer Health). 2026.


Paleogenomics reveals leprosy at the late antique burial site of Fallward in northern Germany
Myburgh DA, da Silva NA, Romeyer-Dherbey JH, et al. iScience. Elsevier BV. 2026; 29 (11): 1 - 15. 


Dermoscopic Patterns in Granulomatous Diseases: A Narrative Review
Sunil SS, Korecka K, Polańska A. Journal of Clinical Medicine. MDPI AG. 2026; 15 (20): 1 - 13. 

 



 



 



Case Reports

Probable leprosy-associated systemic AA amyloidosis presenting as end-stage kidney disease in an adolescent: diagnostic and therapeutic challenges in a resource-limited endemic setting
Tanod DV, Susalit E, Nugroho P. Kidney International Case Reports. Elsevier BV. 2026.


Multibacillary Leprosy Presenting as Chronic Progressive Polyneuropathy Initially Diagnosed as Probable Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Diagnostic Pitfall
Goyal J, Gupta S, Mahendra A, et al. Cureus. Springer Science and Business Media LLC. 2026; 18 (10): 1 - 7. 


Multibacillary Lepromatous Leprosy in an Endemic Area: A Two-Year Diagnostic Delay and the Role of Slit-Skin Smear and PCR
Zumaque Carrascal AM, Berrocal C, Aguado Torrez LE, et al. Cureus. Springer Science and Business Media LLC. 2026; 18 (10): 1 – 7.


Pure Neuritic Leprosy Masquerading as Diabetic Neuropathy: A Diagnostic Challenge
Borthakur K, Mondal SS, Basu K, et al. Bengal Physician Journal. Jaypee Brothers Medical Publishing. 2026; 13 (3): 200 - 202. 

 



 



Latest News

 


 



Medieval leprosy hospital uncovered in Lincoln [BBC]


Meet the 6 Recipients of the ILDS’ 2027 Young Dermatologist International Achievement Awards [The Dermatology Digest]


Countries endorse the multi-communicable disease elimination approach towards a disease-free Eastern Mediterranean Region [World Health Organization Eastern Mediterranean Region]


Why Leprosy Care Comes Late in Tanzania: Stigma, Witchcraft Beliefs and Failing Clinics [Bioengineer]

 


Bharat's Story: Living with leprosy and empowered with confidence [EMMS International]


UP to draw up five-year action plan to tackle leprosy [Hindustan Times]


Nigeria demands protection for people with albinism, leprosy [Peoples Gazette]


Lumbini Province to Launch Skin Disease Screening Campaign Across All Districts [Ratopati]

 



 



Upcoming Events

 


 



13th Edition of the EDCTP Forum

Location: Madrid, Spain
Date: 5 – 9 April, 2027

Over the past two decades, the biennial European & Developing Countries Clinical Trials Partnership (EDCTP) Forum has evolved to become a cornerstone event for global health research, bringing together leading voices advancing the fight against infectious diseases in sub-Saharan Africa. It showcases the latest scientific breakthroughs, highlights impactful capacity-building efforts, and creates a space for vibrant cross-regional collaboration.
 
 

 





 

 



 


 



 



Links

 



Info Hansen - An innovative hub for knowledge sharing about Hansen's Disease
 


ALLF - Official website of the Association des Léprologues de Langue Française
 


LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 


InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 


ILEP newsletter archive


GPZL newsletter subscription


WHO Goodwill Ambassador's Leprosy Bulletin


Leprosy Review


Leprosy Review Repository (1928-2001)


Fontilles Revista de Leprología


Indian Journal of Leprosy


Hansenologia Internationalis


HARP -  Hansen's Disease Antimicrobial Resistance Profiles

 




GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our
privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can
update your preferences or unsubscribe from this list at any time.

 


___________________________________________________________________________

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << edit...@gmail.com

 


--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/leprosymailinglist/7d051a45-eabb-4b78-8730-86424a17799en%40googlegroups.com.